Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.

Yedjou CG, Mbemi AT, Noubissi F, Tchounwou SS, Tsabang N, Payton M, Miele L, Tchounwou PB.

Nutrients. 2019 Feb 4;11(2). pii: E336. doi: 10.3390/nu11020336. Review.

2.

Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Barrington WE, Schenk JM, Etzioni R, Arnold KB, Neuhouser ML, Thompson IM Jr, Lucia MS, Kristal AR.

JAMA Oncol. 2015 Jun;1(3):342-9. doi: 10.1001/jamaoncol.2015.0513. Erratum in: JAMA Oncol. 2015 Jun;1(3):322.

3.

Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.

Drake BF, Keane TE, Mosley CM, Adams SA, Elder KT, Modayil MV, Ureda JR, Hebert JR.

J S C Med Assoc. 2006 Aug;102(7):241-9. Review.

PMID:
17319238
4.

Prostate cancer screening in African American men: barriers and methods for improvement.

Reynolds D.

Am J Mens Health. 2008 Jun;2(2):172-7. doi: 10.1177/1557988307312784. Epub 2008 Jan 23. Review.

PMID:
19477781
5.

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Lago-Hernandez C, Choueiri TK, Elfiky AA, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Kim SP, Lathan CS, Trinh QD, Nguyen PL.

J Geriatr Oncol. 2014 Oct 1;5(4):352-8. doi: 10.1016/j.jgo.2014.05.001. Epub 2014 May 23.

PMID:
24862107
6.

Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.

Kelly SP, Rosenberg PS, Anderson WF, Andreotti G, Younes N, Cleary SD, Cook MB.

Eur Urol. 2017 Feb;71(2):195-201. doi: 10.1016/j.eururo.2016.05.011. Epub 2016 Jul 27.

7.

Age-related racial disparities in prostate cancer patients: A systematic review.

He T, Mullins CD.

Ethn Health. 2017 Apr;22(2):184-195. doi: 10.1080/13557858.2016.1235682. Epub 2016 Oct 5. Review.

8.

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

Moul JW, Sesterhenn IA, Connelly RR, Douglas T, Srivastava S, Mostofi FK, McLeod DG.

JAMA. 1995 Oct 25;274(16):1277-81.

PMID:
7563532
9.

Demographic, Social Support, and Community Differences in Predictors of African-American and White Men Receiving Prostate Cancer Screening in the United States.

Dickey SL, Cormier EM, Whyte J 4th, Graven L, Ralston PA.

Public Health Nurs. 2016 Nov;33(6):483-492. doi: 10.1111/phn.12245. Epub 2016 Jan 21.

PMID:
26790837
10.

Reducing prostate cancer racial disparity: evidence for aggressive early prostate cancer PSA testing of African American men.

Powell IJ, Vigneau FD, Bock CH, Ruterbusch J, Heilbrun LK.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1505-11. doi: 10.1158/1055-9965.EPI-13-1328. Epub 2014 May 6.

11.

Physician-patient discussions with african american men about prostate cancer screening.

Ross LE, Powe BD, Taylor YJ, Howard DL.

Am J Mens Health. 2008 Jun;2(2):156-64. doi: 10.1177/1557988307309323. Epub 2007 Dec 5.

PMID:
19477779
12.

Association of African-American ethnic background with survival in men with metastatic prostate cancer.

Thompson I, Tangen C, Tolcher A, Crawford E, Eisenberger M, Moinpour C.

J Natl Cancer Inst. 2001 Feb 7;93(3):219-25.

PMID:
11158191
13.

Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.

DeSantis CE, Siegel RL, Sauer AG, Miller KD, Fedewa SA, Alcaraz KI, Jemal A.

CA Cancer J Clin. 2016 Jul;66(4):290-308. doi: 10.3322/caac.21340. Epub 2016 Feb 22.

14.

Prostate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research.

Chornokur G, Kumar NB.

Cancer Causes Control. 2013 Aug;24(8):1465-80. doi: 10.1007/s10552-013-0241-x. Epub 2013 Jun 5. Review.

15.

Reducing prostate cancer morbidity and mortality in African American men: issues and challenges.

Jones RA, Underwood SM, Rivers BM.

Clin J Oncol Nurs. 2007 Dec;11(6):865-72. Review.

PMID:
18063545
16.
17.

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.

Mahal BA, Ziehr DR, Aizer AA, Hyatt AS, Sammon JD, Schmid M, Choueiri TK, Hu JC, Sweeney CJ, Beard CJ, D'Amico AV, Martin NE, Lathan C, Kim SP, Trinh QD, Nguyen PL.

Urol Oncol. 2014 Nov;32(8):1285-91. doi: 10.1016/j.urolonc.2014.04.014. Epub 2014 May 17.

PMID:
24846344
18.

Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.

Arnsrud Godtman R, Holmberg E, Lilja H, Stranne J, Hugosson J.

Eur Urol. 2015 Sep;68(3):354-60. doi: 10.1016/j.eururo.2014.12.006. Epub 2014 Dec 31.

PMID:
25556937
19.

African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.

Sanchez-Ortiz RF, Troncoso P, Babaian RJ, Lloreta J, Johnston DA, Pettaway CA.

Cancer. 2006 Jul 1;107(1):75-82.

20.

Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study.

Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, Wilkens LR, John EM, Howe GR, Dreon DM, West DW, Paffenbarger RS Jr.

Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):795-804.

Supplemental Content

Support Center